YaleLewisWangMD

Cardiology • Minneapolis, MN

Interventional Cardiology, Peripheral Endovascular Interventional Cardiology

Physician

Join to view full profile

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wang's full profile

Already have an account?

Office
800 E 28th St
Suite 300
Minneapolis, MN 55407
Phone+1 612-863-3900

Fax+1 612-863-1681

Education & Training

Cleveland Clinic FoundationFellowship, Endovascular Therapies, 2001 - 2001
University of MinnesotaFellowship, Interventional Cardiology, 1999 - 2000
University of MinnesotaFellowship, Cardiovascular Disease, 1996 - 2000
University of MinnesotaResidency, Internal Medicine, 1993 - 1996
University of Minnesota Medical SchoolClass of 1993

Certifications & Licensure

MN State Medical License 1994 - 2025
OH State Medical License 2001 - 2002
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology
American Society of HypertensionHypertension Specialist

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Top Doctor Minnesota Monthly Top Doctors
Fellow SCAI
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension Start of enrollment: 2011 Sep 01
Completed
Not Applicable
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions Start of enrollment: 2015 May 01
Completed
Not Applicable
SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study Start of enrollment: 2015 Jun 01
Completed
Not Applicable
SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System Start of enrollment: 2015 Jul 01
Active, not recruiting
Not Applicable
A Study of the ReCor Medical Paradise System in Clinical Hypertension Start of enrollment: 2016 Mar 01
Active, not recruiting
Not Applicable
RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort) Start of enrollment: 2018 May 14
Completed
Not Applicable
Disrupt CAD III With the Shockwave Coronary IVL System Start of enrollment: 2019 Jan 09
Completed
Not Applicable
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension Start of enrollment: 2018 Dec 14
Active, not recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

54 citations
Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study.
Timothy D. Henry, Alan T. Hirsch, Jo Anne Goldman, Yale L. Wang, Daniel L. Lips
Gene Therapy. 2011-08-01
59 citations
Clinical Characteristics and Outcomes of STEMI Patients With Cardiogenic Shock and Cardiac Arrest
Mohamed Omer, Jeffrey Tyler, Timothy D. Henry, Ross Garberich, Scott W. Sharkey
JACC. Cardiovascular Interventions. 2020-05-25
277 citations
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
Michael Böhm, Kazuomi Kario, David E. Kandzari, Felix Mahfoud, Michael A. Weber
Lancet. 2020-05-02

Journal Articles

Prevalence, Trends, and Outcomes of Higher Risk Percutaneous Coronary Interventions Among Patients Without Acute Coronary Syndromes☆☆☆
Ivan Chavez, M Nicholas Burke, Daniel Lips, Jay Traverse, Emmanouil S Brilakis, Anil Poulose, Michael Mooney, Paul Sorajja, Yale Wang, ScienceDirect
Meta‐Analysis of the Impact of Successful Chronic Total Occlusion Percutaneous Coronary Intervention on Left Ventricular Systolic Function and Reverse Remodeling
Ivan Chavez, Yale Wang, Emmanouil S Brilakis, Louis P Kohl, Daniel Lips, Michael Mooney, Paul Sorajja, Anil Poulose, M Nicholas Burke, Jay Traverse, Journal of Interventional Cardiology

Press Mentions

High Blood Pressure Is Billion-Dollar Target for Device MakersMay 4th, 2019

Research History

Minneapolis Heart Institute Foundation2001 - Present
St. Paul Heart Clinic2000 - 2001
American Heart Association Research Fellowship1991 - 1992

Professional Memberships

American College of Cardiology - ACC
Fellow
American Heart Association - AHA
Member
Society for Cardiovascular Angiography and Interventions - SCAI
Fellow
American Society of Hypertension - ASH
Hypertension Specialist